SB1822

Medical marijuana licenses; authorizing certain research license; requiring promulgation of certain rules. Effective date.

Introduced·2/2/26
Int Text

Oklahoma SB1822 authorizes the creation of a research license for medical marijuana studies and sets an effective date.

Oklahoma SB1822 allows the Oklahoma Medical Marijuana Authority to issue a research license for analyzing patient-reported outcomes related to medical marijuana use. Research licensees can evaluate available products and conduct studies, including surveys and data collection. The initial fee for a research license is $500, and the Authority must establish rules for license issuance, application approvals, compliance monitoring, and reporting. The act takes effect on November 1, 2026.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Business and Insurance Committee
Next
Committee decision

Sponsors

0
1
R
Democratic CaucusRepublican Caucus

History

Feb 3

Senate

Second Reading referred to Business and Insurance

Feb 2

Senate

First Reading

Feb 2

Senate

Authored by Senator Jett